Evaluating Different Doses of Orelabrutinib in MCL

Clinical trial NCT05978739 · COMPLETED

Trial details

NCT number: NCT05978739
Sponsor: InnoCare Pharma Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2023-08-18
Primary completion: 2024-12-10
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.